Home Healthcare Dermatology Drugs Market
dermatology drugs market

Dermatology Drugs Market [(By Therapeutic Area (Atopic Dermatitis, Psoriasis, Acne, Rosacea), By Marketed Therapies (Biologics, Oral Drugs, Topical Drugs), By Approved Treatments (etanercept (Enbrel), infliximab (Remicade), adalimumab (Humira), ustekinumab (Stelara), secukinumab (Cosentyx), ixekizumab (Taltz), golimumab (Simponi), brodalumab (Siliq), and guselkamab (Tremfya), and By Region]: Market Size & Forecast, 2017 – 2022

  • Published Date: Feb 2018
  • Pages: 75
  • Format: PDF
  • Report ID: PM1106
  • Base Year: 2016
  • Historical Data: 2015-2016

Inquire Before Buying

Have any questions before purchase, please specify your details and we will get back to you

By using this form you agree with the storage and handling of your data by this website.

Polaris Market Research
Global Dermatology Drugs Market Size & Share - Industry Report, 2022